Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

Perion Network Ltd. (PERI) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Perion Network is a global Internet consumer software company that designs and markets a suite of downloadable consumer products, including customized e-mail software products, software for sharing digital photo creations, a photo discovery tool, and PC optimization software. PERI’s two … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

iCo Therapeutics, Inc. (ICO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

iCo Therapeutics is a biotechnology company focused on redosing or reformulating drugs with clinical history for new or expanded indications. The company has exclusive worldwide rights to three products: iCo-007, in phase 2 for the treatment of Diabetic Macular Edema … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Safeguard Scientifics, Inc. (SFE) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Safeguard Scientifics is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage and early stage financings. SFE primarily focuses on investments in companies engaged in the technology … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Affymax, Inc. (AFFY) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Affymax provides scalable, innovative genomic analysis tools and reagents for discovery, exploration, validation and genetic testing. The company’s technologies are used by pharmaceutical, diagnostic and biotechnology companies, as well as academic, government and nonprofit research institutes. AFFX is headquartered in … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Broadwind Energy, Inc. (BWEN) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Broadwind Energy provides its customers in the energy and infrastructure markets with gears and gearing systems, specialty weldments, wind turbine gearing, and wind turbine towers and services. BWEN sells its products through its sales force and manufacturers’ representatives primarily in … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Dendreon Corp. (DNDN) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Dendreon is a biotechnology company focused on targeting cancer through the discovery, development, commercialization and manufacturing of novel therapeutics that may significantly improve cancer treatment options for patients. The company specializes in antigen identification, engineering and cell processing to produce … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

NeurogesX, Inc. (NGSX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

NeurogesX is a specialty pharmaceutical company focused on the development and commercialization of a portfolio of novel non-opioid, pain management therapies to address unmet medical needs. NGSX’ most advanced product candidate, NGX-1998, is a topically applied liquid formulation designed to … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Bio-Path Holdings, Inc. (BPTH) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Bio-Path Holdings is a biotechnology company focused on developing therapeutic products utilizing its proprietary liposomal delivery technology designed to systemically distribute nucleic acid drugs throughout the human body via intravenous transfusion. The company’s lead product candidate, Liposomal Grb-2, is in … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

PDL BioPharma, Inc. (PDLI) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

PDL BioPharma is a biotech company with a patented process to create humanized antibodies. PDLI engages in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Synthesis Energy Systems, Inc. (SYMX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Synthesis Energy Systems provides technology, equipment and engineering services for the conversion of low rank, low cost coal and biomass feedstocks into energy and chemical products. SYMX coverts feedstocks into energy and chemical products through the application of its advanced … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment